Biogen Inc. ( BIIB) - Key Metrics
BIIB Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $15.54 | -$0.33 | $3.49 | $3.79 |
| 2025Q3 | $16.74 | $3.18 | $8.68 | $8.36 |
| 2025Q2 | $18.13 | $4.35 | $1.10 | $0.99 |
| 2025Q1 | $16.66 | $1.65 | $1.78 | $1.45 |
BIIB Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -133.33 |
| 2025Q3 | ? | 11.01 |
| 2025Q2 | ? | 7.22 |
| 2025Q1 | ? | 20.75 |
BIIB Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 2.58% | ? |
| 2025Q4 | 2.15% | ? |
| 2025Q3 | 5.97% | ? |
| 2025Q2 | 0.79% | ? |
| 2025Q1 | 1.06% | ? |
BIIB
Price: $203.16
52 week price:
Payout Ratio Range:
Earnings Per Share: 9.30 USD
P/E Ratio: 20.34
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: United States
Volume: 789100
Ebitda: 1.6 billionMarket Capitalization: 31.9 billion